We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App





Coronavirus Attacks Blood Vessels Across Body to Cause Multiple Organ Failure, Finds Study

By HospiMedica International staff writers
Posted on 27 Apr 2020
A study conducted by University Hospital Zurich (Zurich, Switzerland) has found that the coronavirus attacks the lining of blood vessels across the body, ultimately resulting in multiple organ failure.

The researchers found that the deadly virus caused more than just pneumonia and enters the endothelium (layer of cells), which acts as a defense line of the blood vessels, causing circulation problems in the smallest of blood vessels. More...
The coronavirus then reduces the blood flow to different parts of the body and eventually stops blood circulation. This also explains why smokers and those with pre-existing conditions, such as hypertension, or high blood pressure, diabetes, obesity and established cardiovascular disease, having a weakened endothelial function, or unhealthy blood vessels, were more vulnerable to the novel coronavirus.

Based on an analysis of three cases, the study found viral elements within endothelial cells, which line the inside of blood vessels, and inflammatory cells in COVID-19 patients. Autopsies performed on other COVID-19 patients also found their blood vessel linings to be “full of virus” and impaired functioning of vessels in all their organs. Based on these findings, the researchers have suggested therapies to stabilize the endothelium in addition to vaccination that reduces virus replication, and believe that strengthening vascular health could hold the key to treating COVID-19 patients.

“This virus does not only attack the lungs, it attacks the vessels everywhere,” said Frank Ruschitzka, an author of the paper from University Hospital Zurich. “From what we do see clinically, patients have problems in all organs – in the heart, kidney, intestine, everywhere. All patients who are at risk and the elderly should be treated very well for the underlying cardiovascular conditions. The better they are treated, the more likely they are to survive the COVID-19 infection.”

Related Links:
University Hospital Zurich


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The new procedure can help surgeons remove cancer while protecting major vessels and bile ducts (Photo courtesy of Adobe Stock)

Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive

Tumors located in the caudate lobe of the liver present a major surgical challenge. This deep section of the liver sits close to critical blood vessels, making traditional surgical access difficult and... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.